SK-N-AS Cells

The SK-N-AS cell line is derived from a neuroblastoma of a human child and is extensively used in neuro-oncology research. Neuroblastoma is a type of cancer that arises from neural crest cells and predominantly affects children. SK-N-AS cells provide a valuable model for studying the biology and treatment of neuroblastoma, particularly in understanding the molecular mechanisms driving tumor development and progression. This cell line is characterized by its relatively undifferentiated state, which makes it useful for examining the pathways involved in neuronal differentiation and malignancy.
SK-N-AS cells exhibit an adherent growth pattern and possess a neuroblastic morphology. They express various markers associated with neural crest cells and neuroblastoma, including neuron-specific enolase (NSE) and chromogranin A. Researchers utilize SK-N-AS cells to investigate the genetic and epigenetic changes associated with neuroblastoma, such as MYCN amplification and ALK mutations. These cells are also employed in high-throughput drug screening and preclinical testing of novel chemotherapeutic agents and targeted therapies. Additionally, SK-N-AS cells are used to study the mechanisms of resistance to conventional therapies and to develop strategies to overcome such resistance. The relevance of SK-N-AS cells in neuroblastoma research underscores their importance in advancing our understanding of this aggressive childhood cancer and in improving therapeutic approaches for affected patients.